Baseline Characteristics of the Intention-to-Treat KARISMA

Intention to Treat Analysis

Baseline Characteristics of the Intention-to-Treat KARISMA Population

ORs and 95% CIs of breast cancer for breast density and

Percentages of Participants With Severe Symptoms at 6 Months in the

Social Sciences, Free Full-Text

Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial. - Abstract - Europe PMC

Yvonne WENGSTRÖM, Professor (Full), OCN, PhD, Professor, Karolinska Institutet, Solna, KI, Nursing Division

Humans of New York creator Brandon Stanton calls out Indian version amid copyright row: 'I've stayed quiet

Viruses May 2021 - Browse Articles

Chapter 7: Health, Wellbeing and the Changing Structure of Communities

116933 PDFs Review articles in MAMMOGRAPHY

Table III from Intention-to-treat analysis and accounting for missing data in orthopaedic randomized clinical trials.

Randomized controlled trial: Going for the Gold

Jose TAPIA, Karolinska Institutet, Solna, KI, Department of Medical Epidemiology and Biostatistics

Andrea DISCACCIATI, Karolinska Institutet, Solna, KI, Department of Medical Epidemiology and Biostatistics